The University of Michigan Health Stroke Program is accredited as a Comprehensive Stroke Center by the Joint Commission. We have repeatedly been designated as an American Heart Association Gold Plus stroke hospital, the highest stroke quality designation. This award recognizes hospitals that provide consistently excellent care following evidence based guidelines. The AHA has recognized the quality of stroke care provided at U-M since 2005.
The University of Michigan Health Systems Cerebrovascular Program is one of a select few which offers both open surgical and minimally- invasive treatment for aneurysm patients, with a new Neuro Interventional suite that makes it possible to detect and repair aneurysms in the same room, with a team of neurosurgeons and neuroradiologistsworking closely together.
The University of Michigan Health Systems Cerebrovascular Program diagnoses and treats cerebral arteriovenous malformation and is one of a select few which offers open surgical, minimally- invasive and stereotactic radiosurgery treatments.
Retinoblastoma is a malignant tumor in the retina of a child’s eye. Although retinoblastoma may occur at any age, it most often occurs in younger children before the age of five years. The tumor may be in one eye only or in both eyes. Retinoblastoma can occur randomly or it can be hereditary.
Hereditary Hemorrhagic Telangiectasia (HHT) is a genetic disorder that affects about one in 5,000 people and commonly causes nosebleeds, with more frequent nosebleeds typically starting after about age 12. Patients with HHT have a tendency to form blood vessels that are abnormal, fragile, and bleed more easily. Michigan Medicine has a multidisciplinary team of physicians to treat HHT, including specialists in otolaryngology (for nosebleeds), pulmonary diseases, interventional radiology, gastroenterology, neurosurgery, liver diseases, cardiology, heart failure, dermatology, radiation oncology, hematology-oncology and associated pediatric subspecialties.
There are many different specialists who treat patients with HHT. Many patients will eventually see two or more types of specialists, especially later in adulthood. Specialists who treat HHT include otolaryngologists (ear, nose & throat doctors), interventional radiologists (to treat AVMs), hematologists (to help manage anemia), and more.
The University of Michigan Health System’s Neurointerventional Radiology Division uses minimally-invasive procedures to diagnose and treat a wide range of cerebrovascular disorders (involving the brain, head, neck, spine and spinal cord regions).
The Stroke Program at the University of Michigan brings together specialists in multiple disciplines to offer the highest level of comprehensive stroke care to patients. We are the first hospital in Michigan to achieve the American Heart Association’s (AHA) Gold Plus rating for stroke care. This award recognizes hospitals that provide consistently excellent care following evidence based guidelines. The AHA has recognized the quality of stroke care provided at Michigan Medicine since 2005.
Stroke resources for patients and their families including a Stroke Support Group, Michigan Medicine Care Guides, and patient videos.
Treatment for a stroke depends on whether you’ve been diagnosed with an ischemic or hemorrhagic stroke, how long it’s been since your stroke occurred and other factors. Your doctor will recommend the best treatment for you. Ischemic stroke treatment includes tPA clot-busting medication and endovascular thrombectomy. Hemorrhagic stroke treament includes clipping, coiling, craniotomy and craniectomy.
At the Stroke Clinic in the Frankel Cardiovascular Center, stroke specialists aim to prevent you from suffering a recurring stroke and to determine what caused your stroke. As part of the Michigan Comprehensive Stroke Program, you have access to stroke specialists in multiple specialties working to help you to not have a recurring stroke.
